Scarica l'app Stockscreener
13.08
1.79%
0.23
Dopo l'orario di chiusura:
12.52
-0.56
-4.28%
Syndax Pharmaceuticals Inc Borsa (SNDX) Ultime notizie
Syndax Pharmaceuticals' SWOT analysis: stock poised for growth amid FDA approvals - Investing.com
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) for Potential Breaches of Fiduciary Duty By Its Board of Directors - The Eastern Progress Online
Franklin Resources Inc. Grows Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
SNDX stock touches 52-week low at $13.26 amid market challenges - Investing.com Canada
Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 1-Year LowShould You Sell? - MarketBeat
State Street Corp Has $72.59 Million Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Fmr LLC Has $948,000 Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
(SNDX) Technical Pivots with Risk Controls - Stock Traders Daily
Syndax Pharmaceuticals Announces Additional Positive Data for Revuforj from Augment-101 Trial in Relapsed or Refractory Mnpm1 Aml and Beat Aml Frontline Combination Trial - Marketscreener.com
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Short Interest Update - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Down – Time to Sell? - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.65 Million Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
BNP Paribas Financial Markets Buys 16,663 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Syndax Pharmaceuticals' SWOT analysis: biotech stock poised for growth amid challenges - Investing.com
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap DownTime to Sell? - MarketBeat
The Manufacturers Life Insurance Company Has $918,000 Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Syndax Pharmaceuticals’ (SNDX) “Buy” Rating Reiterated at HC Wainwright - Defense World
Y Intercept Hong Kong Ltd Buys 61,916 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
SNDX stock touches 52-week low at $14.99 amid market shifts By Investing.com - Investing.com South Africa
SNDX stock touches 52-week low at $14.99 amid market shifts - Investing.com Canada
SNDXSyndax Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Syndax Pharmaceuticals (NASDAQ:SNDX) Given Buy Rating at HC Wainwright - MarketBeat
While Syndax Pharmaceuticals (NASDAQ:SNDX) shareholders have made 85% in 5 years, increasing losses might now be front of mind as stock sheds 6.8% this week - Simply Wall St
Wellington Management Group LLP Cuts Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Two Sigma Advisers LP Purchases 48,100 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Syndax Pharmaceuticals Announces Additional Positive Data for Revuforj®? from Augment-101 Trial in Relapsed or Refractory Mnpm1 Aml and Beat Aml Frontline Combination Trial - Marketscreener.com
Syndax's Revuforj Shows Breakthrough 100% Response Rate in AML Clinical Trial Data - StockTitan
Charles Schwab Investment Management Inc. Grows Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Quantbot Technologies LP Acquires Shares of 2,542 Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Syndax's Revuforj Shows Remarkable 82% Response Rate in Leukemia Clinical Trials at ASH Meeting - StockTitan
Verition Fund Management LLC Has $1.53 Million Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
BlackRock, Inc. Acquires Additional Shares in Syndax Pharmaceuti - GuruFocus.com
(SNDX) Proactive Strategies - Stock Traders Daily
Syndax Pharmaceuticals (STU:1T3) Change In Prepaid Assets : €-6.79 Mil (TTM As of Sep. 2024) - GuruFocus.com
Syndax Pharmaceuticals (STU:1T3) COGS-to-Revenue : 0.00 (As of Sep. 2024) - GuruFocus.com
Point72 Asset Management L.P. Sells 67,086 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
SNDX (Syndax Pharmaceuticals) FCF Margin % : -498.58% (As of Sep. 2024) - GuruFocus.com
Why Is Syndax Pharmaceuticals, Inc. (SNDX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Insider Monkey
Parkman Healthcare Partners LLC Has $9.78 Million Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Syndax Pharmaceuticals Awards Key Talent with Strategic Stock Options Package - StockTitan
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $37.64 Average PT from Analysts - MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Eventide Asset Management LLC Buys New Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Syndax Pharmaceuticals, Inc. announced that it expects to receive funding from Kyowa Hakko Kirin Co., Ltd. - Marketscreener.com
Syndax Pharmaceuticals, Inc. announced that it expects to receive $30 million in funding from Hercules Capital, Inc. - Marketscreener.com
Syndax Announces Participation at the Citi 2024 Global Healthcare Conference - StockTitan
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Purchased by Propel Bio Management LLC - MarketBeat
Syndax Pharmaceuticals' SWOT analysis: stock outlook brightens on FDA approvals - Investing.com Canada
Long Term Trading Analysis for (SNDX) - Stock Traders Daily
Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $38.00 Price Target at JPMorgan Chase & Co. - Defense World
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Lowered by StockNews.com - Defense World
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Makes New $15.17 Million Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
StockNews.com Downgrades Syndax Pharmaceuticals (NASDAQ:SNDX) to Sell - MarketBeat
Atria Investments Inc Makes New Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Kura Signs Leukemia Pact with Kyowa Kirin After Losing Race to Syndax - BioSpace
Citigroup Boosts Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $45.00 - Defense World
What is B. Riley’s Forecast for SNDX FY2024 Earnings? - Defense World
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):